Bristol-Myers Squibb Pharmaceutical Limited

Bristol-Myers Squibb House, Uxbridge Business Park, Sanderson Road, Uxbridge, Middlesex, UB8 1DH , UK
Telephone: +44 (0)1895 523 000
Fax: +44 (0)1895 523 010
Medical Information Direct Line: +44 (0)1895 523 740
Medical Information e-mail: medical.information@bms.com
Medical Information Fax: +44 (0)1895 523 677

Patient Information Leaflet last updated on the eMC: 19/07/2010
PIL Lipostat 10 mg, 20 mg and 40 mg Tablets

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 19/07/2010 and displayed until Current
Reasons for adding or updating:
  • Change to side-effects
Updated on 28/01/2010 and displayed until 19/07/2010
Reasons for adding or updating:
  • Change due to harmonisation of PIL.
  • Change to storage instructions
Updated on 28/07/2006 and displayed until 28/01/2010
Reasons for adding or updating:
  • Change to storage instructions
Updated on 30/05/2006 and displayed until 28/07/2006
Reasons for adding or updating:
  • New PIL for eMC ie a PIL for an existing product but one that is new to the eMC

Active Ingredients/Generics

 
   pravastatin sodium